Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001393905-24-000399
Filing Date
2024-11-25
Accepted
2024-11-25 17:03:46
Documents
7
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 REPORT bhsc_6k.htm 6-K 14861
2 UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS bhsc_ex991.htm EX-99.1 299781
3 MANAGEMENT'S DISCUSSION AND ANALYSIS bhsc_ex992.htm EX-99.2 113036
4 CERTIFICATE - CEO bhsc_ex993.htm EX-99.3 6580
5 CERTIFICATE - CFO bhsc_ex994.htm EX-99.4 6689
6 IMAGE bhscex992_1.jpg GRAPHIC 10586
7 IMAGE bhscex992_2.jpg GRAPHIC 11580
  Complete submission text file 0001393905-24-000399.txt   472982
Mailing Address 1140 - 625 HOWE STREET VANCOUVER A1 V6C 2T6
Business Address 1140 - 625 HOWE STREET VANCOUVER A1 V6C 2T6 6046221186
BIOHARVEST SCIENCES INC. (Filer) CIK: 0001723464 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42389 | Film No.: 241496870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)